Trulieve Cannabis (TCNNF) Cash & Equivalents (2020 - 2026)
Trulieve Cannabis has reported Cash & Equivalents over the past 6 years, most recently at $255.5 million for Q4 2025.
- For Q4 2025, Cash & Equivalents rose 7.01% year-over-year to $255.5 million; the TTM value through Dec 2025 reached $255.5 million, up 7.01%, while the annual FY2025 figure was $255.5 million, 7.01% up from the prior year.
- Cash & Equivalents for Q4 2025 was $255.5 million at Trulieve Cannabis, down from $449.2 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $449.2 million in Q3 2025 and troughed at $823000.0 in Q1 2022.
- A 5-year average of $226.2 million and a median of $220.1 million in 2021 define the central range for Cash & Equivalents.
- Biggest five-year swings in Cash & Equivalents: crashed 99.49% in 2022 and later soared 22456.74% in 2023.
- Year by year, Cash & Equivalents stood at $226.6 million in 2021, then fell by 8.58% to $207.2 million in 2022, then decreased by 2.81% to $201.4 million in 2023, then rose by 18.59% to $238.8 million in 2024, then increased by 7.01% to $255.5 million in 2025.
- Business Quant data shows Cash & Equivalents for TCNNF at $255.5 million in Q4 2025, $449.2 million in Q3 2025, and $392.6 million in Q2 2025.